JPRN-C000000307已完成3 期
Randomized phase III trial of postoperative whole brain radiation therapy compared with salvage stereotactic radiosurgery in patients with one to four brain metastasis: Japan Clinical Oncology Group Study (JCOG 0504) - Phase III trial of postoperative WBRT vs. salvage SRT for one to four brain metastasis. JCOG0504
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 270 人开始时间: 2006年1月18日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 270
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ or mucosal cancer (2) pregnant or breast-feeding women (3) severe mental disease (4) allergic to gadolinium contained contrast agents
研究者
相似试验
进行中（未招募）
1 期
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckCTIS2024-513206-65-00Groupe Oncologie Radiotherapie Tete Cou674
进行中（未招募）
1 期
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckSquamous cell carcinoma treated by primary surgeryStage III, stage IV (American Joint Committee on Cancer 7th edition)Oral cavity, oropharynx, hypopharynx or larynxMedDRA version: 21.0Level: PTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-004936-13-PLGORTEC680
进行中（未招募）
1 期
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckEUCTR2017-004936-13-GRGORTEC680
进行中（未招募）
1 期
randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckEUCTR2017-004936-13-BEGORTEC680
已完成
3 期
Randomized phase III trial of surgery followed by mFOLFOX6 as adjuvant chemotherapy versus peri-operative mFOLFOX6 plus cetuximab for KRAS wild type resectable liver metastases of colorectal cancerResectable colorectal liver metastasesJPRN-UMIN000007787Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo500